Terns sold to Merck for 13% lower than pharma’s initial offer because of clinical datanews2026-04-07T15:30:06+00:00April 7th, 2026|Endpoints News|
Gilead continues dealmaking streak with $3.15B Tubulis buy for ADCsnews2026-04-07T12:17:00+00:00April 7th, 2026|Endpoints News|
Takeda ends partnership with Denali amid restructuringnews2026-04-06T14:19:14+00:00April 6th, 2026|Endpoints News|
Neurocrine will pay $2.9B for Soleno and its Prader-Willi medicinenews2026-04-06T11:32:55+00:00April 6th, 2026|Endpoints News|
OpenLoop Health has acquired nutrition startup Season Healthnews2026-04-02T20:27:52+00:00April 2nd, 2026|Endpoints News|
Noom plans push into peptides beyond weight loss drugsnews2026-04-01T20:47:39+00:00April 1st, 2026|Endpoints News|
Paragon offshoot Korsana to go public in reverse merger for Alzheimer’s worknews2026-04-01T15:20:48+00:00April 1st, 2026|Endpoints News|
Pharma goes on $25.5B, eight-day acquisition spreenews2026-03-31T19:32:28+00:00March 31st, 2026|Endpoints News|
Merck joins forces with Infinimmune to find therapeutic antibodiesnews2026-03-31T12:00:11+00:00March 31st, 2026|Endpoints News|
